Efficacy of omega-3 PUFAs in depression: A meta-analysis.
If we're going to try omega-3 at all, does the product I'd be buying actually deliver about a gram of EPA a day, with EPA making up most of the total?
Top of the evidence hierarchy, independently funded. how we score evidence
Caveat on this rating: The paper carries a published erratum (Transl Psychiatry 2021;11(1):465) and a published critique (Transl Psychiatry 2022;12(1):298); neither is a retraction, but both belong alongside it. Dose and formulation subgroups drawn out of a meta-analysis of heterogeneous small trials are exploratory — the Cochrane review reached a similar overall effect size and judged it very low certainty and likely biased upward.
Fish-oil, EPA and DHA products sold for mood are dietary supplements under DSHEA: no FDA review of safety or effectiveness happens before they go on sale, and none is approved to treat depression or any other psychiatric condition. Prescription omega-3 drugs do exist, but for lipids, not mood. Icosapent ethyl (Vascepa) is FDA-approved as an adjunct to maximally tolerated statin therapy to reduce cardiovascular events in adults with triglycerides at or above 150 mg/dL plus established cardiovascular disease or diabetes, and as an adjunct to diet for severe (at or above 500 mg/dL) hypertriglyceridemia; omega-3-acid ethyl esters (Lovaza and generics) are approved only as an adjunct to diet for severe hypertriglyceridemia. Neither label carries a psychiatric indication. Dose matters and labels obscure it: the depression literature is dosed in grams of EPA, while a capsule marked "fish oil 1000 mg" typically contains only a few hundred milligrams of EPA, so the number on the front of the bottle is usually not the number the trials used.
Pooling 26 double-blind placebo-controlled trials (2,160 participants), omega-3 had an overall effect on depressive symptoms of SMD -0.28 (P=0.004) — small. The benefit was concentrated in formulations that were pure EPA or at least 60% EPA at doses of 1 g/day or less of EPA (SMD -0.50 and -1.03 respectively), while DHA-pure and DHA-predominant formulations showed no benefit. The pooled effect is smaller than the change most clinicians would notice, and the subgroup pattern is a hypothesis about dosing, not a tested rule.
Worth asking
If we're going to try omega-3 at all, does the product I'd be buying actually deliver about a gram of EPA a day, with EPA making up most of the total?
What to watch for
Evidence quality tells you whether to trust the finding — not whether the treatment is safe. These are the risks this research reports.
- Heart & circulation
- Interactions with other medicines
- Stomach & digestion
Source
Efficacy of omega-3 PUFAs in depression: A meta-analysis. — Liao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, Fan B, Lu C, McIntyre RS. (2019)
Reputable peer-reviewed journal
Read the source: https://doi.org/10.1038/s41398-019-0515-5
DOI: 10.1038/s41398-019-0515-5
How this was scored
- Study design
- Meta-analysis of randomised trials
- Funding
- Independently funded
- Published in
- Reputable peer-reviewed journal
- Sample size
- 2,160
- Preregistered
- No
- Conflicts disclosed
- Yes
- Independent of proponent
- Yes
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026. Last verified September 10, 2026.
Where we put this study in context
Questions
How strong is the evidence behind this?
veisund rates this source "gold standard". Top of the evidence hierarchy, independently funded. It scores 89 out of 100 on our published rubric. One caveat travels with that badge: The paper carries a published erratum (Transl Psychiatry 2021;11(1):465) and a published critique (Transl Psychiatry 2022;12(1):298); neither is a retraction, but both belong alongside it. Dose and formulation subgroups drawn out of a meta-analysis of heterogeneous small trials are exploratory — the Cochrane review reached a similar overall effect size and judged it very low certainty and likely biased upward. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
Efficacy of omega-3 PUFAs in depression: A meta-analysis. — Liao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, Fan B, Lu C, McIntyre RS. (2019). Published in: Reputable peer-reviewed journal. DOI: 10.1038/s41398-019-0515-5. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: Meta-analysis of randomised trials. Funding: Independently funded. The researchers were independent of whoever benefits from the result. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is omega-3, fish oil, epa, dha, n-3 pufa, omega-3 fatty acids, krill oil, algal oil FDA approved for this use?
No. Its current status is: Not FDA-evaluated for this use. Fish-oil, EPA and DHA products sold for mood are dietary supplements under DSHEA: no FDA review of safety or effectiveness happens before they go on sale, and none is approved to treat depression or any other psychiatric condition. Prescription omega-3 drugs do exist, but for lipids, not mood. Icosapent ethyl (Vascepa) is FDA-approved as an adjunct to maximally tolerated statin therapy to reduce cardiovascular events in adults with triglycerides at or above 150 mg/dL plus established cardiovascular disease or diabetes, and as an adjunct to diet for severe (at or above 500 mg/dL) hypertriglyceridemia; omega-3-acid ethyl esters (Lovaza and generics) are approved only as an adjunct to diet for severe hypertriglyceridemia. Neither label carries a psychiatric indication. Dose matters and labels obscure it: the depression literature is dosed in grams of EPA, while a capsule marked "fish oil 1000 mg" typically contains only a few hundred milligrams of EPA, so the number on the front of the bottle is usually not the number the trials used.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.